News
-
-
COMMUNIQUÉ DE PRESSE
Verve Group SE Announces Uplisting to the Regulated Market of the Frankfurt Stock Exchange and Publishes its Listing Prospectus
Verve Group SE announces uplisting to the Regulated Market of the Frankfurt Stock Exchange and publishes its listing prospectus, aiming for broader investor access and enhancing transparency -
-
COMMUNIQUÉ DE PRESSE
Annual General Meeting of Hannover Rück SE approves dividend increase to EUR 9.00 per share
Hannover Rück SE's Annual General Meeting approves dividend increase to EUR 9.00 per share, showcasing continued profitable growth and innovation. CEO highlights commitment to resilience and future responsibility -
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
Jaguar Health's crofelemer, the only oral drug approved under FDA's Botanical Guidance, shows promising results in rare disease and cancer therapy-related diarrhea programs. Expected Q2-Q4 2025 catalysts discussed -
-
-
